Pillstats
Rx only · Powder, For Suspension · Oral

Cefixime

Cefixime

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)25033
US makers2 labelers
Packages7
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.03$2.07$3.10$4.13Dec 2025Apr 2026Jul 2026
$3.487
Latest avg · Jul 22, 2026
-1%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3677341.1K1.5K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.2K
Rx · 2026 Q1
87K
Units dispensed
+5%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Aurobindo Pharma Limitedunknown4SUPPLYING
Lupin Pharmaceuticals,Inc.unknown3SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Aug 21, 2024
    RECALLRecall (Class II): Cefixime for Oral Suspension USP, 100 mg/5 mL, 50 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Ba…

    Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study. — Recalling firm: Lupin Pharmaceuticals Inc. — USA nationwide.

  • May 30, 2024
    RECALLRecall (Class II): Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only, Manufactured for: …

    Failed Content Uniformity Specifications — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide in the US

  • Jan 3, 2024
    RECALLRecall (Class II): Cefixime for Oral Suspension 100mg/5mL, 50 mL bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore…

    Failed Impurities/Degradation Specifications — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide in the USA

  • Apr 29, 2021
    RECALLRecall (Class II): Cefixime for Oral Suspension USP 100 mg/5mL, 50mL HDPE bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc. B…

    Subpotent Drug — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide within the United States

  • Apr 15, 2020
    RECALLRecall (Class II): Cefixime for Oral Suspension USP, 100mg/5mL, Rx Only, Manufactured for: Lupin Pharmaceutical, Inc. Baltimore, Maryland …

    Subpotent Drug: low out of specification (OOS) test result observed in long term stability study. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide with the United States and Puerto Rico.